Skip to main content

Diabetes

  • APhA announces 25 companies participating in Project Impact: Diabetes

    WASHINGTON — The American Pharmacists Association Foundation announced Monday the selection of 25 companies, community health departments and other organizations — collectively known as “communities” — that will take part in the foundation’s initiative to improve care for people disproportionately affected by diabetes across the United States.

  • Walgreens to host walkathon, health fair event

    HOLLYWOOD, Fla. — The Diabetes Research Institute Foundation on Wednesday announced that the first-ever Walk with Walgreens Family Fun Day & Health Fair will take place April 10 at 14 locations across Florida.

    Additionally, 851 Walgreens stores throughout the state and parts of Georgia and Alabama will be selling "scannables" in the amounts of $1, $5 and $10 that customers can write their names on and help decorate the stores' walls through April to benefit the Diabetes Research Institute.

  • Actos cuts Type 2 diabetes risk among majority of patients, study finds

    SAN ANTONIO — A drug for Type 2 diabetes made by Takeda Pharmaceutical taken in the morning prevented the disease from developing in nearly three-quarters of patients who were at risk, according to a new study in the New England Journal of Medicine.

    Researchers enrolled 602 patients through the University of Texas Health Science Center San Antonio and seven other centers and administered Actos (pioglitazone) to them, finding that it prevented Type 2 diabetes in 72% of those whose obesity, ethnicity and other factors put them at risk for the disease.

  • Novo Nordisk says Levemir is effective in treating young Type 1 diabetes patients

    COPENHAGEN — Novo Nordisk said new data showed that its basal insulin analog is just as effective as human basal insulin in Type 1 diabetes patients ages 2 to 5 years.

  • AACE, Takeda say online resource will provide accurate healthcare information

    JACKSONVILLE, Fla., and DEERFIELD, Ill. — The American Association of Clinical Endocrinologists has teamed up with drug maker Takeda to develop an online resource that will be reviewed and evaluated by top medical experts.

    AACE and Takeda will offer a compendium of existing reliable resources specific to Type 2 diabetes, divided into various categories (e.g., management, lifestyle and tools) and reviewed by experts to help healthcare professionals guide their patients and caregivers as they attempt to cut through the clutter of the many resources available.

  • Annual Diabetes Alert Day encourages public to know risk

    ALEXANDRIA, Va. — The annual "wake-up call" that asks the American public to find out if they are at risk for developing Type 2 diabetes was held Tuesday.

  • AAPCHO addresses diabetes with new program

    OAKLAND, Calif. — The Association of Asian Pacific Community Health Organizations has introduced a program that aims to reduce the secondary complications of diabetes among specific ethnic groups living with the disease.

    AAPCHO said its five-year diabetes program addresses diabetes among vulnerable populations in three Asian-American, Native Hawaiian and other Pacific Islander communities:

  • Nipro Diagnostics promotes senior execs

    FT. LAUDERDALE, Fla. — Nipro Diagnostics, a provider of diabetes monitoring and management products, announced the promotion of Gregg Johnson to SVP consumer healthcare and Lisa Nardi to VP marketing. Both will continue reporting to Scott Verner, Nipro president.

X
This ad will auto-close in 10 seconds